Skip to content

Bioventus BVS Gross Profit

Gross Profit at other companies

Stryker logo
StrykerSYK
$3.81B+1.8%
Medtronic logo
MedtronicMDT
$6.41B+10.9%
SI-BONE, Inc. logo
SI-BONE, Inc.SIBN
$41.94M+11.3%
Avanos Medical logo
Avanos MedicalAVNS
$94.2M+4.9%
Enovis logo
EnovisENOV
$365.49M+10.0%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH

Other financials

Income statement

See full
Revenue$132.1M+6.6%
Operating income$8.4M+72.8%
Net income$3.1M+218%
EPS (diluted)$0.04+200%

Balance sheet

See full
Cash & equivalents$35.8M+57.2%
Total debt$288.4M-21.2%
Total equity$188.9M+27.5%
Total assets$650.5M-5.9%

Cash flow

See full
Operating cash flow$8.9M+146%
CapEx$574.0K-30.5%
Free cash flow$8.4M+141%

Valuation

See full
Market cap$659.19M+51.7%
Enterprise value$911.76M+17.2%
P/E23.1×
P/S1.1×+0.4×

Profitability

See full
Gross margin68.7%+1.2pp
Operating margin10%
Net margin4.9%+3.2pp
FCF margin17.5%+13.2pp

Returns & leverage

See full
Return on equity16.9%+10.9pp
Debt / equity1.5×-0.9×
Current ratio1.7×+0.3×

Where this comes from

Calculated from Bioventus’s reported figures.

The official record: Bioventus’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bioventus's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bioventus's gross profit?
Bioventus (BVS) reported gross profit of $90.77M in Q1 2026.
How has Bioventus's gross profit changed year-over-year?
Bioventus's gross profit increased by 9.3% year-over-year, from $83.06M to $90.77M.
What is the long-term trend for Bioventus's gross profit?
Over 4 years (2021 to 2025), Bioventus's gross profit has grown at a 6.4% compound annual growth rate (CAGR), from $302.71M to $388.16M.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.